Stocks News

LAST PRICE
58.1000
TODAY'S CHANGE (%)
Trending Down-0.3600 (-0.6158%)

Bid / Lots
57.6000/ 10
Ask / Lots
59.9800/ 5
Open / Previous Close
58.5800 / 58.4600
Day Range
Low 57.6000
High 60.0200
52 Week Range
Low 42.2100
High 76.9800
Volume
538,478
above average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Today
- DJ Immunocore Holdings Initiated at Outperform by Leerink Partners, from 7 hours ago by Dow Jones
  7 hours ago by Dow Jones
  Companies Mentioned: IMCR
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/IMCR/analyst-ratings
  
  (END) Dow Jones Newswires
  
  April 29, 2024 09:11 ET (13:11 GMT)
- Leerink Partners Starts Immunocore Holdings With Outperform Rating, $74 Price Target, from 9 hours ago by MT Newswires
  9 hours ago by MT Newswires
  Companies Mentioned: IMCR
  07:15 AM EDT, 04/29/2024 (MT Newswires) -- Immunocore Holdings (IMCR) has an average rating of buy and price targets ranging from $49.79 to $74.59, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic resea...
Apr 24, 2024
- Immunocore announces upcoming presentation and posters at ASCO 2024, from 10:00AM ET on Wednesday Apr 24, 2024 by GlobeNewswire
  10:00AM ET on Wednesday Apr 24, 2024 by GlobeNewswire
  Companies Mentioned: IMCR
- Immunocore announces upcoming presentation and posters at ASCO 2024, from 10:00AM ET on Wednesday Apr 24, 2024 by Dow Jones
  10:00AM ET on Wednesday Apr 24, 2024 by Dow Jones
  Companies Mentioned: IMCR
  
  Immunocore announces upcoming presentation and posters at ASCO 2024
  
  Immunocore announces upcoming presentation and posters at ASCO 2024
  
  Phase 1 expansion data in immune checkpoints pre-treated cutaneous melanoma for brenetafusp (IMC-F106C targeting PRAME) to be presented during oral abstract session
Apr 23, 2024
- DJ Immunocore Holdings Price Target Maintained With a $92.00/Share by Guggenheim, from 1:08PM ET on Tuesday Apr 23, 2024 by Dow Jones
  1:08PM ET on Tuesday Apr 23, 2024 by Dow Jones
  Companies Mentioned: IMCR
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/IMCR/analyst-ratings
  
  (END) Dow Jones Newswires
  
  April 23, 2024 13:08 ET (17:08 GMT)

Today
- Corcept Completes Enrollment in Phase 4 CATALYST Trial, from 8 hours ago by GlobeNewswire
  8 hours ago by GlobeNewswire
  Companies Mentioned: CORT
Apr 25, 2024
- Levi & Korsinsky, LLP Notifies Shareholders of Corcept Therapeutics Incorporated (CORT) an Upcoming Claims Deadline in a Class Action Settlement, from 12:33PM ET on Thursday Apr 25, 2024 by Accesswire
  12:33PM ET on Thursday Apr 25, 2024 by Accesswire
  Companies Mentioned: CORT
- European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Thursday Trading, from 11:06AM ET on Thursday Apr 25, 2024 by MT Newswires
  11:06AM ET on Thursday Apr 25, 2024 by MT Newswires
  Companies Mentioned: AVDL, SNY, TRIB, UL, NCNA, AUTL, OPRA, AZN, BCS, CALT, BPTSY, TCBP, ASND, CLLS, BDRX, EDAP
Apr 24, 2024
- Corcept Therapeutics to Announce First Quarter Financial Results, Provide Corporate Update and Host Conference Call, from 4:05PM ET on Wednesday Apr 24, 2024 by GlobeNewswire
  4:05PM ET on Wednesday Apr 24, 2024 by GlobeNewswire
  Companies Mentioned: CORT
- Innoviva Specialty Therapeutics' Positive Phase 3 Oral Zoliflodacin Data for the Treatment of Uncomplicated Gonorrhea Announced at ESCMID Global 2024, from 7:00AM ET on Wednesday Apr 24, 2024 by Business Wire
  7:00AM ET on Wednesday Apr 24, 2024 by Business Wire
  Companies Mentioned: INVA
Apr 23, 2024
- European Equities Traded in the US as American Depositary Receipts Jump in Tuesday Trading, from 11:05AM ET on Tuesday Apr 23, 2024 by MT Newswires
  11:05AM ET on Tuesday Apr 23, 2024 by MT Newswires
  Companies Mentioned: AVDL, NTZ, SAP, TRIB, SQNS, GRFS, AKTX, BHP, BPTSY, TCBP, DBVT, ADAP, DEO, BDRX
- Ligand to Report First Quarter 2024 Financial Results on May 7, 2024, from 8:31AM ET on Tuesday Apr 23, 2024 by Business Wire
  8:31AM ET on Tuesday Apr 23, 2024 by Business Wire
  Companies Mentioned: LGND
Apr 22, 2024
- European Equities Traded in the US as American Depositary Receipts Rebound in Monday Trading, from 11:03AM ET on Monday Apr 22, 2024 by MT Newswires
  11:03AM ET on Monday Apr 22, 2024 by MT Newswires
  Companies Mentioned: AVDL, FMS, NOK, VOD, VRNA, NCNA, GNFT, AKTX, BCYC, CALT, TCBP, DBVT, CLLS, BDRX
- Corcept Announces Positive Results From Open-Label Portion of Pivotal Phase 3 GRACE Trial in Patients With Cushing's Syndrome, from 8:00AM ET on Monday Apr 22, 2024 by GlobeNewswire
  8:00AM ET on Monday Apr 22, 2024 by GlobeNewswire
  Companies Mentioned: CORT
Apr 18, 2024
- Levi & Korsinsky, LLP Notifies Shareholders of Corcept Therapeutics Incorporated (CORT) an Upcoming Claims Deadline in a Class Action Settlement, from 12:16PM ET on Thursday Apr 18, 2024 by Accesswire
  12:16PM ET on Thursday Apr 18, 2024 by Accesswire
  Companies Mentioned: CORT

Immunocore Holdings PLC
NASDAQ:IMCRUnited States

Search Criteria

Today

DJ Immunocore Holdings Initiated at Outperform by Leerink Partners, from 7 hours ago by Dow Jones

Leerink Partners Starts Immunocore Holdings With Outperform Rating, $74 Price Target, from 9 hours ago by MT Newswires

Apr 24, 2024

Immunocore announces upcoming presentation and posters at ASCO 2024, from 10:00AM ET on Wednesday Apr 24, 2024 by GlobeNewswire

Immunocore announces upcoming presentation and posters at ASCO 2024, from 10:00AM ET on Wednesday Apr 24, 2024 by Dow Jones

Apr 23, 2024

DJ Immunocore Holdings Price Target Maintained With a $92.00/Share by Guggenheim, from 1:08PM ET on Tuesday Apr 23, 2024 by Dow Jones

Peers Headlines

Today

Corcept Completes Enrollment in Phase 4 CATALYST Trial, from 8 hours ago by GlobeNewswire

Apr 25, 2024

Levi & Korsinsky, LLP Notifies Shareholders of Corcept Therapeutics Incorporated (CORT) an Upcoming Claims Deadline in a Class Action Settlement, from 12:33PM ET on Thursday Apr 25, 2024 by Accesswire

European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Thursday Trading, from 11:06AM ET on Thursday Apr 25, 2024 by MT Newswires

Apr 24, 2024

Corcept Therapeutics to Announce First Quarter Financial Results, Provide Corporate Update and Host Conference Call, from 4:05PM ET on Wednesday Apr 24, 2024 by GlobeNewswire

Innoviva Specialty Therapeutics' Positive Phase 3 Oral Zoliflodacin Data for the Treatment of Uncomplicated Gonorrhea Announced at ESCMID Global 2024, from 7:00AM ET on Wednesday Apr 24, 2024 by Business Wire

Apr 23, 2024

European Equities Traded in the US as American Depositary Receipts Jump in Tuesday Trading, from 11:05AM ET on Tuesday Apr 23, 2024 by MT Newswires

Ligand to Report First Quarter 2024 Financial Results on May 7, 2024, from 8:31AM ET on Tuesday Apr 23, 2024 by Business Wire

Apr 22, 2024

European Equities Traded in the US as American Depositary Receipts Rebound in Monday Trading, from 11:03AM ET on Monday Apr 22, 2024 by MT Newswires

Corcept Announces Positive Results From Open-Label Portion of Pivotal Phase 3 GRACE Trial in Patients With Cushing's Syndrome, from 8:00AM ET on Monday Apr 22, 2024 by GlobeNewswire

Apr 18, 2024

Levi & Korsinsky, LLP Notifies Shareholders of Corcept Therapeutics Incorporated (CORT) an Upcoming Claims Deadline in a Class Action Settlement, from 12:16PM ET on Thursday Apr 18, 2024 by Accesswire